EQS-News: APONTIS PHARMA AG / Key word(s): 9 Month figures/Change in Forecast APONTIS PHARMA reports profitable revenue growth for Single Pill combinations in 9M 2024 – revenue guidance adjusted ...

Rather than bribing and wheedling physicians to pretty-please-prescribe-our-drug, websites allow companies to deal drugs ...

Novo Nordisk said the side effects in trials so far for its experimental obesity drug CagriSema were similar to its GLP-1 ...

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

A Durham company says its drug is pacing for over $400 million in revenue this year. The goal is $1 billion.

On the other hand, recent history suggests that pharma-related topics like drug pricing are one of the few areas where bipartisan legislation is still possible. Drug pricing: The Inflation ...

Laser Photonics Corporation has acquired Control Micro Systems to expand its market reach into the pharmaceutical industry ... and capitalize on growing demand for laser-based drug delivery and ...

Laser Photonics Corporation (“LPC” or the “Company”) (NASDAQ: LASE), a global leader in industrial laser systems for cleaning ...

As the 1970s drew to an end, a shift began in the way the pharma industry focused its energies. In 1977, Tagamet, an ulcer medication, became the first ever “blockbuster” drug, earning its ...

The unlisted ingredients can cause "life threatening" drops in blood pressure when used in combination with other prescription drugs.

The company operates in a single business segment: human pharmaceutical products. An array of pharmaceutical pills with the company's logo on the bottle. Eli Lilly and Company (NYSE:LLY) is on 19th ...

A trader works at the New York Stock Exchange in New York City, U.S., November 6, 2024. REUTERS/Andrew Kelly/File Photo Cigna Group said on Monday it is not pursuing a combination with rival ...